Furukawa J - Search Results

1

Treatment outcomes of molecular targeted therapy following nivolumab in metastatic renal cell carcinoma.

Bando Y, Furukawa J, Terakawa T, Harada K, Hinata N, Nakano Y, Fujisawa M. Bando Y, et al. Among authors: furukawa j. Jpn J Clin Oncol. 2021 Aug 1;51(8):1313-1318. doi: 10.1093/jjco/hyab068. Jpn J Clin Oncol. 2021. PMID: 33954587

2

High dose chemotherapy including paclitaxel (T-ICE) combined with peripheral blood stem cell transplantation for male germ cell tumor. Preliminary report.

Hara I, Yamada Y, Kumano M, Furukawa J, Yamanaka K, Fujisawa M. Hara I, et al. Among authors: furukawa j. Int J Urol. 2005 Dec;12(12):1074-8. doi: 10.1111/j.1442-2042.2005.01235.x. Int J Urol. 2005. PMID: 16409617

3

Interleukin-21 gene transfection into mouse bladder cancer cells results in tumor rejection through the cytotoxic T lymphocyte response.

Furukawa J, Hara I, Nagai H, Yao A, Oniki S, Fujisawa M. Furukawa J, et al. J Urol. 2006 Sep;176(3):1198-203. doi: 10.1016/j.juro.2006.04.037. J Urol. 2006. PMID: 16890725

4

Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.

Hara I, Miyake H, Yamada Y, Yamanaka K, Furukawa J, Kumano M, Takenaka A, Fujisawa M. Hara I, et al. Among authors: furukawa j. Anticancer Drugs. 2006 Oct;17(9):1057-66. doi: 10.1097/01.cad.0000231469.46664.12. Anticancer Drugs. 2006. PMID: 17001179

5

Stable hematopoietic recovery after peripheral blood stem cell transplantation in patients receiving high-dose chemotherapy for advanced germ cell tumors.

Kumano M, Miyake H, Hara I, Furukawa J, Takenaka A, Fujisawa M. Kumano M, et al. Among authors: furukawa j. Anticancer Res. 2006 Nov-Dec;26(6C):4965-8. Anticancer Res. 2006. PMID: 17214371 Free article.

6

First-line high-dose chemotherapy combined with peripheral blood stem cell transplantation for patients with advanced extragonadal germ cell tumors.

Kumano M, Miyake H, Hara I, Furukawa J, Takenaka A, Fujisawa M. Kumano M, et al. Among authors: furukawa j. Int J Urol. 2007 Apr;14(4):336-8. doi: 10.1111/j.1442-2042.2006.01718.x. Int J Urol. 2007. PMID: 17470166

7

Clinical outcome of orthotopic neobladder replacement in patients with a solitary functioning kidney.

Furukawa J, Miyake H, Hara I, Takenaka A, Fujisawa M. Furukawa J, et al. Int J Urol. 2007 May;14(5):398-401. doi: 10.1111/j.1442-2042.2006.01730.x. Int J Urol. 2007. PMID: 17511720

8

Persistent expression of Aurora-A after neoadjuvant hormonal therapy as a predictor of a poor clinical outcome in patients undergoing radical prostatectomy for prostate cancer.

Furukawa J, Miyake H, Takenaka A, Hara I, Fujisawa M. Furukawa J, et al. BJU Int. 2007 Aug;100(2):310-4. doi: 10.1111/j.1464-410X.2007.06982.x. Epub 2007 May 19. BJU Int. 2007. PMID: 17511772

9

Upper urinary tract recurrence following radical cystectomy for bladder cancer.

Furukawa J, Miyake H, Hara I, Takenaka A, Fujisawa M. Furukawa J, et al. Int J Urol. 2007 Jun;14(6):496-9. doi: 10.1111/j.1442-2042.2007.01776.x. Int J Urol. 2007. PMID: 17593092

10

Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.

Kumano M, Hara I, Furukawa J, Oniki S, Nagai H, Miyake H, Fujisawa M. Kumano M, et al. Among authors: furukawa j. J Urol. 2007 Oct;178(4 Pt 1):1504-9. doi: 10.1016/j.juro.2007.05.115. Epub 2007 Aug 16. J Urol. 2007. PMID: 17707061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters